In January 2018, the national centre of Azerbaijan became the 130th full member of the WHO Programme for International Drug Monitoring - and there is much progress to report.
WHO programme / 23 June 2022
Luxembourg joined the WHO Programme for International Drug Monitoring in 2020, and being part of the network has already supported the growth of the pharmacovigilance department.
WHO programme / 04 May 2022
Prof. Hervé Le Louët has resigned from his position as CEO of UMC due to family reasons. The recruitment process for next CEO starts immediately.
WHO programme / 30 March 2022
Recent additions mean the WHO Programme for International Drug Monitoring now stands at 143 full members and 28 associate members.
WHO programme / 30 March 2021